All About Multiple Sclerosis

More MS news articles for May 2004

Low Dose Rebif Not Effective in SPMS

May 1, 2004
Art Mellor
Boston Cure Project

Here's a quick negative study that found that Interferon beta-1a (Rebif(R)), 22 micro g subcutaneously once weekly, in patients with secondary progressive MS did not delay progression of disease. My guess is they'll try higher doses next.

Copyright © 2004, Boston Cure Project